EF Hutton Initiates Coverage On Imunon with Buy Rating, Announces Price Target of $29
Portfolio Pulse from Benzinga Newsdesk
EF Hutton has initiated coverage on Imunon (NASDAQ:IMNN) with a Buy rating and set a price target of $29, indicating a positive outlook for the company's stock.
September 23, 2024 | 12:32 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
EF Hutton's analyst Jason Kolbert has initiated coverage on Imunon with a Buy rating and a price target of $29, suggesting a positive short-term outlook for the stock.
The initiation of coverage with a Buy rating and a specific price target of $29 by EF Hutton is likely to positively influence investor sentiment and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100